Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Studies of PPAR agonists have yielded mixed results for people with fatty liver disease.
A quick overview of our reporting on the 53rd International Liver Congress in Vienna
In a small ongoing study, the treatment showed an anti-cholestatic effect.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.